Investors
Share in a tablet made for the way pharmacies already work. Tablet presses produce thousands a day, which brings the cost of manufacture down and puts the medicine within reach of more people.
Partnerships
Turning research into a medicine programme takes more than one team. We welcome partners who are aligned with our mission, vision and goals, and who bring practical experience. Our goal is to help cannabis become a mainstream medicine and improve the lives of everyone who can benefit from it.
Where we can work together
Share in a tablet made for the way pharmacies already work. Tablet presses produce thousands a day, which brings the cost of manufacture down and puts the medicine within reach of more people.
Help build Australia's sovereign capability in pharmaceutical manufacturing, from Australian-grown plant to finished tablet.
Work with a licensed GMP manufacturer on process, packaging and tablet production at scale.
Discuss commercial relationships in Australia and the requirements for potential overseas markets.
Sovereign capability
By scaling up tablet manufacture at Thornleigh, TCann Pty Ltd, the licensed manufacturer behind Promethean BioPharma, is adding to Australia's sovereign pharmaceutical capability. The partners we need now are investors and government who want efficient manufacturing built here.
We want the knowledge and manufacturing capability developed here to support a business with a future beyond Australia. Any overseas opportunity depends on the evidence, local regulatory requirements and the right commercial relationships.
That is a reason to build carefully now and to speak with partners who understand the markets they work in.
Tell us about your organisation and the work you have in mind.